BOT - Botanix Pharmaceuticals

[alex90]

Phase IIb results expected sometime from now up to August.
Should have a nice rise if we see positive results.
Any thoughts on the company?

 

[petee]

BNE 500K market cap with osteoporosis/ arthritis drugs phase 11

I believe BNE is about to be rerated given the huge demand for drugs to combat Osteoporosis and Arthritis.These are truly needed worldwide in a big way and BNE are progressing well in this area.
A tiny market cap of 500K.
Would appriciate others thoughts.
Petee

 

[AussieBoy]

BNE - BONE MEDICAL LIMITED

Man, this stock exploded right through the roof this morning. Was up as high as 257% at one point. I believe it also shot up a lot not so long ago. Does anyone know much about this company?

EDIT: Now up 285%

 

[AussieBoy]

Re: BNE - Bone Medical

Looks like there's been some sort of halt in the stock, currently up 300%

 

[Crunched]

Re: BNE - Bone Medical

Yeah what's that about?

 

[Mr Wilson]

Re: BNE - Bone Medical

BNE has gone up %33.33 today,

look's like I might be able to flip it after all,

Is any one else on here invested in BNE ?

 

[Miner]

Re: BNE - Bone Medical

BNE has gone up %33.33 today,

look's like I might be able to flip it after all,

Is any one else on here invested in BNE ?

Yeah what's that about?

Looks like there's been some sort of halt in the stock, currently up 300%

Man, this stock exploded right through the roof this morning. Was up as high as 257% at one point. I believe it also shot up a lot not so long ago. Does anyone know much about this company?

EDIT: Now up 285%

Any one is following this scrip or thread ? Current price is 0.001 and then will be consolidated 50;1 and SI got it at 0.0004. OMG. what happens in one year ? Any comments ?

 

[System]

On July 7th, 2016, Bone Medical Limited (BNE) changed its name and ASX code to Botanix Pharmaceuticals Limited (BOT).

 

[greggles]

Botanix Pharmaceuticals has announced this morning that its recent testing work of the active drug used in the Company's lead acne product, BTX 1503, has shown potent antibacterial activity against both antibiotic resistant and non-resistant strains of Propionibacterium acnes (P. acnes).

I'm always a bit wary of biotech companies simply because of their capacity for dramatic price movement, both up and down. The risk involved can be huge. But if you manage to get on a winner early the returns can be eye watering. All it takes is one successful product.

Anyway, BOT is up today after this morning's announcement. It's currently at 6.9c, up 19% from yesterday's close of 5.8c.

 

[greggles]

Botanix Pharmaceuticals outperforming since my last post in this thread. The one month chart looks great with BOT having soared from 6c to 13c since Christmas after some encouraging announcements.

 

[HelloU]

That was a premature ....(cannot even make a joke out of it)........no announcements as yet. This is the lead out train at work.......vague timings at Q1 2018 announcements Jan/Feb for the pimple study....

 

[HelloU]

ooops, sorry, forget that. Read headline production numbers and thought it had something to do with shares.

(BOT just popped above 10C for any shares interested peeps - noonish 18 January)

bit late now, I buried this in another thread last week after I got somewhat deflated sifting thru all the drugs, movie, god, Don Burke, refugee etc threads whilst looking for something share related.

Even this would have got u 30% in 3 trade days.

I will now try to contribute in a better way.

 

[greggles]

That was a premature ....(cannot even make a joke out of it)........no announcements as yet. This is the lead out train at work.......vague timings at Q1 2018 announcements Jan/Feb for the pimple study....

Sorry for the confusion. When I said encouraging announcements I meant the ones this month that I felt had an encouraging tone to them. I suppose it's the company's job to make them sound that way.

It's true that there are no announcements regarding results of the company's clinical trials as yet, although they are apparently due sometime this quarter.

It has had a good run recently though. There is clearly a lot of confidence in BOT's BTX-1503 acne product.

 

[HelloU]

I am just making this up and living in hope..........if you had just spent a heap of money on a trial, and the money is now already spent and gone, what would be the reasons that you need to have a 20 odd page meeting with the bank manager about the SAME trial?

(and really hoping the answer is not about covering legal actions arising from disfigurement)

 

[HelloU]

halt 24jan18 for results
if this is good then company solid (remember I make stuff up)
this product is not for a nose pimple on saturday night but for those that need real help - as current products have some not so good associations (possibly think I feel bad so need Invocare). Not advice.

 

[greggles]

halt 24jan18 for results
if this is good then company solid (remember I make stuff up)
this product is not for a nose pimple on saturday night but for those that need real help - as current products have some not so good associations (possibly think I feel bad so need Invocare). Not advice.

The accumulation has been pretty relentless with this one, so my guess is the news will probably be positive. I think there may have been some insider trading in the lead up to this trading halt given share price movement and volume in the last couple of days.

Lots of speculation about the trial results, but all will be revealed next week.

 

[greggles]

The accumulation has been pretty relentless with this one, so my guess is the news will probably be positive.

Well, I was right on this one.

BOT announced this morning that its Phase 1b acne patient study, designed to evaluate the safety, tolerability and pharmacology of its lead product for acne BTX 1503, has produced successful results.

From the announcement:

The study achieved all the Company’s BTX 1503 program goals. Top line data indicated that BTX 1503 has an excellent safety profile and is very effective at reducing the number of inflammatory (papules and pustules) and non-inflammatory (white heads and blackheads) acne lesions after 4 weeks of treatment.

Botanix Executive Director Matt Callahan said “These acne study results show that BTX 1503 is potentially a very safe and highly effective therapy for the treatment of acne. The acne market has suffered from a distinct lack of innovative products for more than 20 years and BTX 1503 offers an exciting new alternative to the millions of patients with acne”

“We are extremely excited about the data generated from only 4 weeks of treatment. The large reduction in inflammatory acne lesions observed after this short treatment period, is better than the leading topically applied products currently available on the market. We expect to see even greater reductions in acne lesions and continued safety when treatment with BTX 1503 is extended out to 12 weeks.”

The Phase 1b open label acne study was conducted at four of the leading acne investigative sites in Australia and enrolled 21 subjects with moderate to severe acne, with 18 subjects completing the study. Subjects were treated for 28 days and then assessed for safety, tolerability, and efficacy at Day 28 and at a follow-up visit on Day 35.

Top line data indicated significant reductions in both inflammatory and non-inflammatory lesions and an improvement in patient satisfaction. On average, inflammatory lesions decreased by ~47% by Day 28 of the study. This significant reduction is greater than any other FDA approved topical acne product, for which data is available after 4 weeks of treatment.

BOT up 4c to 17c so far today. The global market for topical acne treatments is huge and if BOT can get a slice of that its value could increase exponentially.

 

[Init]

Any idea why it went up so high followed by 3 days of down? Is this a pump and dump kind of thing or is it just speculation followed by correction to resistance?

 

[greggles]

Any idea why it went up so high followed by 3 days of down? Is this a pump and dump kind of thing or is it just speculation followed by correction to resistance?

BOT has gone from 7c to 16c in less than a month, it is normal that there will be profit taking and a pullback after such a run. No stock keeps going up, at some point sellers will take control and push the price back down.

Also, they went into a trading halt today. They will be announcing a capital raising shortly and some may have been aware of it or anticipated it and sold out, expecting that the raising will be at a lower level than recent highs.

 

[Init]

This might be naieve of me but how did people know the success trial news would be followed by a capital raising before the announcement?

I feel a bit dumb not knowing this info i would have sold at 200% instead of hanging onto my current 100% gain.